Digestives & Intestinal Remedies - Myanmar

  • Myanmar
  • In Myanmar, the revenue in the Digestives & Intestinal Remedies market market is recorded at US$28.49 in 2024.
  • It is projected to experience a steady annual growth rate of 5.03% (CAGR 2024-2029).
  • When compared to other countries worldwide, in China generates the highest revenue in this market, with a staggering US$4,408.00 in 2024.
  • In terms of per capita income, in Myanmar generates US$0.52 in revenue per person in 2024.
  • Myanmar's growing middle class is driving the demand for digestive and intestinal remedies in the OTC pharmaceutical market.

Key regions: Canada, United States, Australia, Brazil, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Myanmar is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences:
Customers in Myanmar are increasingly seeking natural and herbal remedies for digestive and intestinal issues. This shift in preference can be attributed to the growing awareness about the potential side effects of synthetic medications and the desire for more holistic healthcare solutions. As a result, there is a rising demand for products that are derived from natural ingredients and have minimal or no chemical additives.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market in Myanmar is the increasing popularity of traditional medicine practices such as Ayurveda and traditional Chinese medicine. These practices have a long history in Myanmar and are deeply rooted in the country's culture. As a result, there is a growing demand for herbal remedies and traditional formulas that have been used for centuries to treat digestive and intestinal ailments.Another trend in the market is the rising popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for the digestive system. They help restore the natural balance of bacteria in the gut and promote healthy digestion. Probiotic supplements and foods have gained traction in Myanmar as people become more aware of the importance of gut health and its impact on overall well-being.

Local special circumstances:
Myanmar has a rich biodiversity and is home to a wide variety of medicinal plants and herbs. This abundance of natural resources has contributed to the development of a thriving herbal medicine industry in the country. Local manufacturers are capitalizing on this by producing a range of herbal remedies for digestive and intestinal issues. These products are often seen as more affordable and accessible alternatives to imported synthetic medications.

Underlying macroeconomic factors:
The growing middle class in Myanmar is driving the demand for Digestives & Intestinal Remedies. As disposable incomes rise, more people are able to afford healthcare products and are willing to spend on preventive measures to maintain their health. Additionally, the increasing urbanization and modernization in the country have led to changing lifestyles and dietary habits, resulting in a higher incidence of digestive and intestinal problems. This, in turn, has fueled the demand for remedies to address these issues.In conclusion, the Digestives & Intestinal Remedies market in Myanmar is experiencing growth due to changing customer preferences towards natural and herbal remedies, emerging trends in traditional medicine and probiotics, local special circumstances related to the country's rich biodiversity, and underlying macroeconomic factors such as the growing middle class and changing lifestyles.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)